Goodman Group is increasing its presence in the global data centres market, nabbing a Microsoft executive to lead its ...

Tariffs set by US President Donald Trump have upset the global economy but Pure Hydrogen believes it can leverage them to its ...

The ASX has opened higher on April 23, 2025, as US President Donald Trump said he won't "play hardball" with China in trade negotiations.

Telix Pharmaceuticals' quarterly report shows a strong revenue contribution from its acquired nuclear medicine business RLS Radiopharmacies.

AI film studio Wonder thinks it can dramatically slash the cost of producing TV, and Aussie VC fund Blackbird is along for the ride.

The uranium market has been described as "broken", but there's reason to think a price rebound is inevitable. These stocks are getting ready.

In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.

The ASX lit up on Wall Street buzz and hopes of a China trade thaw, sending gold tumbling as risk came back on the menu.

Riversgold’s (ASX:RGL) drilling has expanded the mineralised footprint of its Kalgoorlie East-Northern Zone project.

Big pharma’s jumped into CBD sleep land with Sandoz backing Avecho; could this bring a new rush into ASX CBD stocks like Neurotech?

Experienced antimony miner Andre Booyzen, formerly of Mandalay Resources, will lead Trigg Minerals (ASX:TMG) as its new managing director.

Legacy Minerals’ (ASX:LGM) exploration has identified areas for follow-up at its Bauloora project in New South Wales.